Status:
ACTIVE_NOT_RECRUITING
MRD Assay Evaluates Recurrence and Response Via a Tumor Informed Assessment
Lead Sponsor:
Invitae Corporation
Conditions:
Cancer
Solid Tumor
Eligibility:
All Genders
18+ years
Brief Summary
This study recruits patient with solid tumor types for sample collection and monitoring. Participants will provide blood and archival tissue samples in order to create a Personalized Cancer Monitoring...
Detailed Description
This study involves collection of tumor tissue (from a standard biopsy and/or surgery) as well as blood samples over time in order to allow the creation of a Personalized Cancer Monitoring (PCM) assay...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Stated ability to give informed consent by participant.
- Stated health status of participant as healthy enough to provide Biological Material.
- Individuals diagnosed with solid cancer of any type, including but not limited to colorectal, non-small cell lung, breast, ovarian and bladder cancers, regardless of the length of time since diagnosis and regardless of previous therapies.
- Participant is of any biological sex and \>18 years of age
- Participant has not undergone a blood transfusion within the previous three weeks
- Exclusion Criteria
- Participants who are deemed medically unstable
- Participants who are deemed to be "difficult to draw" blood from.
- Participants who are \<18 years of age
- Participants diagnosed with CNS cancers, sarcomas or hematologic malignancies such as leukemia or lymphoma .
- Participants with more than one primary cancer
- Participants with FFPE slides older than 10 years
- Participants who are pregnant
- Any other reason that, in the Investigator's judgment, that would preclude the participant from being able to participate in the study
- Participants for which a pathology report is not available
Exclusion
Key Trial Info
Start Date :
November 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT05219734
Start Date
November 29 2021
End Date
December 1 2026
Last Update
March 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbus Regional Health
Columbus, Indiana, United States, 47201
2
Onslow Radiation
Jacksonville, North Carolina, United States, 28546